BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22695187)

  • 21. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population.
    Wu O; Chen GP; Chen H; Li XP; Xu JH; Zhao SS; Sheng J; Feng JB; Cai J; Fang XH; Zhang WH; Li LH; Zhang N; Li J; Li JJ; Pan FM; Wang CZ; Ye DQ
    Immunobiology; 2009; 214(5):392-402. PubMed ID: 19362685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific antigen-binding and antibody-secreting lymphocytes associated with the erythrocyte autoantibody responses of NZB and genetically unrelated mice.
    DeHeer DH; Edgington TS
    J Immunol; 1976 Apr; 116(4):1051-8. PubMed ID: 1082901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation.
    Marie-Cardine A; Divay F; Dutot I; Green A; Perdrix A; Boyer O; Contentin N; Tilly H; Tron F; Vannier JP; Jacquot S
    Clin Immunol; 2008 Apr; 127(1):14-25. PubMed ID: 18191619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the human tonsil B cell repertoire by somatic hybridization: occurrence of both "monospecific" and "multispecific" (auto)antibody-secreting cells.
    Logtenberg T; Kroon A; Gmelig-Meyling FH; Ballieux RE
    Eur J Immunol; 1987 Jun; 17(6):855-9. PubMed ID: 3496225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body.
    Cao Y; Gordic M; Kobold S; Lajmi N; Meyer S; Bartels K; Hildebrandt Y; Luetkens T; Ihloff AS; Kröger N; Bokemeyer C; Atanackovic D
    J Immunol Methods; 2010 Jun; 358(1-2):56-65. PubMed ID: 20302874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
    Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
    J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
    Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
    Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus.
    Goeken JA; Layer T; Fleenor S; Laccheo M; Lenert P
    Lupus; 2010 Oct; 19(11):1290-301. PubMed ID: 20605877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR4 promotes B cell maturation: independence and cooperation with B lymphocyte-activating factor.
    Hayashi EA; Granato A; Paiva LS; Bertho AL; Bellio M; Nobrega A
    J Immunol; 2010 May; 184(9):4662-72. PubMed ID: 20357250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fate decisions regulating bone marrow and peripheral B lymphocyte development.
    Monroe JG; Dorshkind K
    Adv Immunol; 2007; 95():1-50. PubMed ID: 17869609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule.
    Lagresle C; Bella C; Daniel PT; Krammer PH; Defrance T
    J Immunol; 1995 Jun; 154(11):5746-56. PubMed ID: 7538529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.
    Kim J; Gross JA; Dillon SR; Min JK; Elkon KB
    Autoimmunity; 2011 Mar; 44(2):69-81. PubMed ID: 21250838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
    Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
    Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro.
    Im Hof M; Williamson L; Summerfield A; Balmer V; Dutoit V; Kandimalla ER; Yu D; Zurbriggen A; Doherr MG; Peel J; Roosje PJ
    Vet Immunol Immunopathol; 2008 Jul; 124(1-2):120-31. PubMed ID: 18452997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase.
    Séité JF; Guerrier T; Cornec D; Jamin C; Youinou P; Hillion S
    J Autoimmun; 2011 Nov; 37(3):190-7. PubMed ID: 21689906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
    Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
    J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-specific activation of autoreactive B cells in normal human individuals.
    Logtenberg T; Kroon A; Gmelig-Meyling FH; Ballieux RE
    Eur J Immunol; 1986 Dec; 16(12):1497-501. PubMed ID: 3493146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease.
    Wang D; John SA; Clements JL; Percy DH; Barton KP; Garrett-Sinha LA
    Int Immunol; 2005 Sep; 17(9):1179-91. PubMed ID: 16051621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients.
    Rudnicka W; Burakowski T; Warnawin E; Jastrzebska M; Bik M; Kontny E; Chorazy-Massalska M; Radzikowska A; Buler M; Maldyk P; Maslinski W
    Eur J Immunol; 2009 May; 39(5):1211-20. PubMed ID: 19384869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.
    Capolunghi F; Rosado MM; Cascioli S; Girolami E; Bordasco S; Vivarelli M; Ruggiero B; Cortis E; Insalaco A; Fantò N; Gallo G; Nucera E; Loiarro M; Sette C; De Santis R; Carsetti R; Ruggiero V
    Rheumatology (Oxford); 2010 Dec; 49(12):2281-9. PubMed ID: 20739362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.